MDLN

Medline
D

MDLN

Arincen64/100B

Medline executives and insider trading

James Boyle reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Medline's insiders sold 159,764,536 shares for 5.51B USD in 24 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
24
Shares sold
159,764,536
Value sold
5.51B USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
996.41M USD
0
6 months
2.37B USD
0
1 year
5.51B USD
0
2 years
5.51B USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
8 Holdings Mozart Manager L.l.c. Bcp 10 percent owner—61,170,8102.35B USD—28 May 2026—
Group Inc. Carlyle 10 percent owner—45,242,1731.63B USD—10 Mar 2026—
Private Ltd Gic 10 percent owner—32,934,5131.15B USD—8 Oct 2026—
Aggregator Ii Lp Mozart 10 percent owner—20,417,040381.91M USD—18 Dec 2025—

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
8 Oct 2026Private Ltd GicSale7,816,98735.15274.77M USD69,408,506Form 4
6 Oct 2026Private Ltd GicSale7,183,01335.05251.76M USD77,225,493Form 4
6 Oct 2026Private Ltd GicSale2,088,98735.0573.22M USD16,453,806Form 4
5 Oct 2026Private Ltd GicSale1,688,69035.7860.42M USD18,542,793Form 4
2 Oct 2026Private Ltd GicSale7,146,94134.33245.35M USD84,408,506Form 4
2 Oct 2026Private Ltd GicSale2,570,99935.3590.88M USD20,231,483Form 4
14 Aug 2026Private Ltd GicSale100,00035.803.58M USD22,802,482Form 4
13 Aug 2026Private Ltd GicSale1,500,00035.8053.70M USD22,902,482Form 4
7 Aug 2026Private Ltd GicSale590,28435.5821.00M USD24,402,482Form 4
6 Aug 2026Private Ltd GicSale271,99435.339.61M USD24,992,766Form 4
5 Aug 2026Private Ltd GicSale1,710,90735.4660.67M USD25,530,471Form 4
5 Aug 2026Private Ltd GicSale265,71136.489.69M USD25,264,760Form 4
28 May 20268 Holdings Mozart Manager L.l.c. BcpSale19,712,32636.54720.24M USD89,537,913Form 4
28 May 20268 Holdings Mozart Manager L.l.c. BcpSale2,256,80036.5482.46M USD10,250,904Form 4
28 May 20268 Holdings Mozart Manager L.l.c. BcpSale9,858,77436.54360.21M USD10,185Form 4

Common questions about Medline's executives and insiders

Source: Financial Modeling Prep